Published in AIDS Weekly, June 27th, 2005
According to recent research published in the journal Antimicrobial Agents and Chemotherapy, "Hoechst 33258 is a compound that binds nucleic acids.
"We report that Hoechst 33258 exhibits antimicrobial activity against Pneumocystis carinii f. sp. muris in a mouse model for P. carinii pneumonia and against Candida albicans and Candida dubliniensis in vitro."
"Relative to saline treatment," researchers wrote, "a 14-day, daily treatment of mice with 37.5 mg of Hoechst 33258/kg of body...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.